The role involves leading end-to-end translational safety strategies for gene-modified CAR T cell products across early- and late-stage clinical programs
Job Summary
The role involves leading end-to-end translational safety strategies for gene-modified CAR T cell products across early- and late-stage clinical programs.
Candidates must possess deep expertise in immunology, molecular/cell biology, or virology to drive robust translational safety oversight.
Bristol Myers Squibb offers competitive benefits including health coverage, financial well-being plans, and flexible time off options.
Matching Summary
The role involves leading end-to-end translational safety strategies for gene-modified CAR T cell products across early- and late-stage clinical programs.
Salary
Base: $152,360 - $184,628; Bonus/Equity: Additional incentive cash and stock opportunities available; Benefits: Health, dental, vision, 401(k), paid time off, and wellness programs included
Skills & Requirements
Must-have
CAR T cell therapy expertise
Translational safety strategy leadership
Genotoxicity evaluation experience
Immunology or virology background
Regulatory framework knowledge
Nice-to-have
Cross-functional collaboration skills
Process improvement mindset
Scientific communication excellence
Fast-paced environment adaptability
Inclusive team culture building
Key Requirements
Bachelor's degree with 8+ years experience OR Master's with 6+ years OR PhD with 4+ years
Ph.D. preferred with 7+ years in clinical trial research and basic sciences
Strong working knowledge of regulatory frameworks and submission requirements